Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C

被引:37
作者
Ido, Y
Chang, KC
Lejeune, WS
Bjercke, RJ
Reiser, KM
Williamson, JR
Tilton, RG
机构
[1] Texas Biotechnol Corp, Dept Pharmacol, Houston, TX 77030 USA
[2] Texas Biotechnol Corp, Dept Immunol, Houston, TX USA
[3] Boston Univ, Diabet & Metab Unit, Boston, MA 02215 USA
[4] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
[5] Univ Calif Davis, Sch Med, Dept Neurol Surg, Davis, CA 95616 USA
关键词
advanced glycation end products; albumin permeation; blood flow; diabetes; vascular endothelial growth factor;
D O I
10.1038/sj.mn.7800079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: These experiments were designed to elucidate mechanisms mediating, vascular dysfunction induced by advanced glycation end product, (AGEs), Methods: Skin chambers were mounted on the backs of Sprague-Dawley rats and 1 week later. granulation tissue that formed in the bottom of dir chamber was exposed twice daily for 7 days to glycated rat serum albumin in the presence and absence of inhibitors of reactive oxygen intermediates, nitric oxide synthase and guanylate cyclase, protein kinase C (PKC). and a neutralizing vascular endothelial growth factor (VEGF) antibody. Vascular I-125-albumin clearance and blood flow were quantified by use Of a double isotope-dilution technique and radiolabeled microspheres. respectively. Results: Albumin permeation and blood flow were increased dose-dependently to a maximum of 2 to 3 times controls by increasing, the extent of glucose modification, the concentration, or the duration of exposure to glycated albumin, These increases were significantly attenuated by probucol and superoxide dismutase, N-G-nitro-L-arginine-methyl ester (L-NAME), a nitric oxide synthase inhibitor. LY83583, a guanylate cyclase inhibitor, and LY333531, a beta -isoform-selective protein kinase C inhibitor. A neutralizing VEGF monoclonal antibody also markedly attenuated the permeability and blood flow increased induced by glycated albumin. Conclusions: These observations indicate potentially important role,, for oxygen free-radicals and nitric oxide in mediating permeability and blood flow changed induced by glycated proteins via mechanisms involving increased protein kinase C activity and VEGF production. Striking similarities in the mechanism by which hyperglycemia and glycated proteins induce vascular dysfunction suggest that a common pathway mediates effects of these different metabolic imbalances on vascular dysfunction.
引用
收藏
页码:251 / 263
页数:13
相关论文
共 55 条
  • [1] Advanced glycation end product-induced activation of NF-kappa B is suppressed by alpha-lipoic acid in cultured endothelial cells
    Bierhaus, A
    Chevion, S
    Chevion, M
    Hofmann, M
    Quehenberger, P
    Illmer, T
    Luther, T
    Berentshtein, E
    Tritschler, H
    Muller, M
    Wahl, P
    Ziegler, R
    Nawroth, PP
    [J]. DIABETES, 1997, 46 (09) : 1481 - 1490
  • [2] STEREOSPECIFIC MONOCLONAL-ANTIBODIES TO NICOTINE AND COTININE AND THEIR USE IN ENZYME-LINKED IMMUNOSORBENT ASSAYS
    BJERCKE, RJ
    COOK, G
    RYCHLIK, N
    GJIKA, HB
    VANVUNAKIS, H
    LANGONE, JJ
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 90 (02) : 203 - 213
  • [3] Acute modulation of albumin microvascular leakage by advanced glycation end products in microcirculation of diabetic rats in vivo
    Bonnardel-Phu, E
    Wautier, JL
    Schmidt, AM
    Avila, C
    Vicaut, E
    [J]. DIABETES, 1999, 48 (10) : 2052 - 2058
  • [4] ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING
    BROWNLEE, M
    [J]. ANNUAL REVIEW OF MEDICINE, 1995, 46 : 223 - 234
  • [5] BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
  • [6] Advanced glycation end products, oxidant stress and vascular lesions
    Chappey, O
    Dosquet, C
    Wautier, MP
    Wautier, JL
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (02) : 97 - 108
  • [7] INCREASE IN DIACYLGLYCEROL MASS IN ISOLATED GLOMERULI BY GLUCOSE FROM DENOVO SYNTHESIS OF GLYCEROLIPIDS
    CRAVEN, PA
    DAVIDSON, CM
    DERUBERTIS, FR
    [J]. DIABETES, 1990, 39 (06) : 667 - 674
  • [8] MODULATION OF VENULAR MICROVESSEL PERMEABILITY BY CALCIUM INFLUX INTO ENDOTHELIAL-CELLS
    CURRY, FE
    [J]. FASEB JOURNAL, 1992, 6 (07) : 2456 - 2466
  • [9] Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis
    Giardino, I
    Fard, AK
    Hatchell, DL
    Brownlee, M
    [J]. DIABETES, 1998, 47 (07) : 1114 - 1120
  • [10] cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i
    He, P
    Zeng, M
    Curry, FE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 274 (06): : H1865 - H1874